The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Lipocomb 20 mg/10 mg hard capsules

20 mg/10 milligram(s) Capsule, hard

EGIS Pharmaceuticals PLCPA1470/004/002

Main Information

Trade NameLipocomb 20 mg/10 mg hard capsules
Active SubstancesRosuvastatin zinc
Ezetimibe
Strength20 mg/10 milligram(s)
Dosage FormCapsule, hard
Licence HolderEGIS Pharmaceuticals PLC
Licence NumberPA1470/004/002

Group Information

ATC CodeC10BA06 rosuvastatin and ezetimibe

Status

Authorised/WithdrawnAuthorised
Licence Issued08/08/2014
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0111-061-009
Interchangeable List DocumentPDF of Interchangeable List
« Back